When you or a loved one has a life-threatening or serious condition, our critical care team is ready 24-hours a day, 365 days a year to serve you. We have two critical care units with 12 beds each, staffed by physicians, nurses, and respiratory trained in the care of critically ill individuals. We have a physical therapy team experienced in implementing an early - mobility program to benefit our patients.
In addition, our critical care department at Raleigh General Hospital is equipped with advanced technology and specialties including acute coronary care unit, cardiac catherization lab, and surgical intensive care.
In a continuing effort to provide progressive health care, Raleigh General Hospital is proud to offer advanced therapy and treatment options to patients in critical and intensive care.
Continuous Renal Replacement Therapy
Another distinctive therapy that Raleigh General Hospital offers is Continuous Renal Replacement Therapy (CRRT) which is designed to replace kidney function for an extended period of time. Blood is purified and recycled into the body in a continuous sequence. This procedure is considered gentler than traditional dialysis, making it a better option for patients who are critically ill and suffering acute kidney injury or renal failure.
Intraaortic Balloon Pump
For patients with certain heart conditions, the use of an Intra-aortic balloon pump is an effective way to help the heart do its work. The balloon pump helps by increasing the amount of oxygen delivered to the heart, while decreasing the workload on the heart. If your doctor has prescribed Intra-aortic balloon pump therapy, you're in good company. More than 140,000 patients throughout the world receive this therapy each year.
One such therapy is Therapeutic Hypothermia, which is a treatment for patients suffering from cardiac arrest who have remained comatose. In this procedure, the patient's body temperature is lowered by several degrees for at least 24 hours in an effort to preserve brain function. Raleigh General plans to implement this therapy in 2017.